Amolyt Pharma

Crinetics

This pharmaceutical company develops oral therapeutics for patients with rare endocrine diseases and endocrine-related tumours.

Pathalys Pharma

This biopharmaceutical company develops treatments for secondary hyperparathyroidism in patients with end-stage kidney disease undergoing dialysis.

Spruce Biosciences

This biopharmaceutical company develops enzyme replacement therapies and small molecules for patients with rare endocrine and neurological disorders.

AdipoPharma

This clinical-stage biotechnology company develops therapeutic peptides to treat insulin resistance and type 2 diabetes for patients with metabolic disorders.

Mereo BioPharma

The company develops clinical-stage therapies for patients with rare diseases, including osteogenesis imperfecta and alpha-1 antitrypsin deficiency-associated lung disease.

AMYL THERAPEUTICS

The company develops pan-amyloid immunotherapies to treat patients with neurodegenerative and rare diseases caused by toxic protein aggregates.

Parabilis Medicines

This biopharmaceutical company develops helical peptide therapeutics to treat cancer and other serious diseases for patients with previously untreatable medical conditions.

Amylyx Pharmaceuticals

This biotechnology company develops pharmaceutical therapies for people with neurodegenerative and endocrine disorders, including amyotrophic lateral sclerosis and post-bariatric hypoglycemia.